Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations-Reference-Cited by-同舟云学术

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations

Published:2018-05 Issue:5 Volume:51 Page:733-738
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Sörstedt Erik,Carlander Christina,Flamholc Leo,Hejdeman Bo,Svedhem Veronica,Sönnerborg Anders,Gisslén Magnus,Yilmaz Aylin

Funder

The Swedish Physicians Against AIDS Research Foundation

Göteborg Medical Society

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference30 articles.

1. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial;Raffi;Lancet Infect Dis,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral load suppression and HIV-1 drug resistance mutations in persons with HIV on TLD/TAFED in Zambia;PLOS ONE;2024-09-06

2. Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation;Viruses;2024-08-30

3. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review;Viruses;2024-03-04

4. Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review;2024-01-07

5. Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden;BMJ Open;2023-03